Active Ingredient: CLOBAZAM
Proprietary Name: CLOBAZAM
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 2.5MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213110
Product Number: 001
Approval Date: Apr 24, 2020
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information